The COVID-19 pandemic has accelerated the globalization of the life sciences industry, driving cross-border collaborations to develop urgently needed treatments, scale up manufacturing and distribution, and fill raw material...more
11/4/2022
/ Asset Seizure ,
Drug Pricing ,
Emerging Markets ,
Enforcement Actions ,
Food and Drug Administration (FDA) ,
Foreign Direct Investment ,
ICSID ,
Investment ,
Life Sciences ,
NAFTA ,
New York Convention ,
Patent Litigation ,
Patents ,
Risk Mitigation ,
Supply Shortages ,
Treaties
On July 8, 2020, the United States Court of Appeals for the Second Circuit decided that federal courts may not order discovery for use in private international commercial arbitrations under 28 U.S.C. § 1782, affirming that a...more